OncoCyte Corporation

Q2 2023 13F Holders

Symbol
IMDX
CUSIP
68235C206
Type
Equity
Class
COM NEW
Num filings
1
Total reported value, excl. options
$3.45 k
Manager Report Date Value ($000) Shares Option Type